I think you're right Paprika. This is far more more significant than the FDA Orphan drug status.
I wonder what a "de risked" valuation would be for PAB. This new deal substantially de risks PAB IMO.
206 mil out of 507 mil, page-7
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $7.419K | 2.372M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 56 | 40557809 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26688875 | 13 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |